Defibrillation Threshold Testing After ICD Implantation in Patients with Chronic Kidney Disease

Abstract Introduction Routine defibrillation threshold (DFT) testing at the time of implantable cardioverter-defibrillator (ICD) implantation is no longer recommended because testing did not improve shock efficacy or reduce arrhythmic death. However, patients with severe chronic kidney disease (CKD)...

Full description

Bibliographic Details

Published in:	Cardiology and Therapy
Main Authors:	Rohit J. Timal, Lano Osman, Joris I. Rotmans, Marianne Bootsma, Bart Mertens, Martin J. Schalij, Ton J. Rabelink, J. Wouter Jukema
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2025-04-01
Subjects:	Implantable cardioverter-defibrillator End-stage kidney disease Chronic kidney disease Dialysis Defibrillation threshold testing Defibrillation efficacy testing
Online Access:	https://doi.org/10.1007/s40119-025-00403-x